
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

